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RESEARCH ARTICLE
Failure of a numerical quality assessment 
scale to identify potential risk of bias in a 
systematic review: a comparison study
Seán R O’Connor1,2,4*, Mark A Tully1,2, Brigid Ryan3, Judy M Bradley4, George D Baxter3  
and Suzanne M McDonough2,4
Abstract 
Background: Assessing methodological quality of primary studies is an essential component of systematic reviews. 
Following a systematic review which used a domain based system [United States Preventative Services Task Force 
(USPSTF)] to assess methodological quality, a commonly used numerical rating scale (Downs and Black) was also 
used to evaluate the included studies and comparisons were made between quality ratings assigned using the two 
different methods. Both tools were used to assess the 20 randomized and quasi-randomized controlled trials examin-
ing an exercise intervention for chronic musculoskeletal pain which were included in the review. Inter-rater reliability 
and levels of agreement were determined using intraclass correlation coefficients (ICC). Influence of quality on pooled 
effect size was examined by calculating the between group standardized mean difference (SMD).
Results: Inter-rater reliability indicated at least substantial levels of agreement for the USPSTF system (ICC 0.85; 95% 
CI 0.66, 0.94) and Downs and Black scale (ICC 0.94; 95% CI 0.84, 0.97). Overall level of agreement between tools (ICC 
0.80; 95% CI 0.57, 0.92) was also good. However, the USPSTF system identified a number of studies (n = 3/20) as “poor” 
due to potential risks of bias. Analysis revealed substantially greater pooled effect sizes in these studies (SMD −2.51; 
95% CI −4.21, −0.82) compared to those rated as “fair” (SMD −0.45; 95% CI −0.65, −0.25) or “good” (SMD −0.38; 95% 
CI −0.69, −0.08).
Conclusions: In this example, use of a numerical rating scale failed to identify studies at increased risk of bias, and 
could have potentially led to imprecise estimates of treatment effect. Although based on a small number of included 
studies within an existing systematic review, we found the domain based system provided a more structured frame-
work by which qualitative decisions concerning overall quality could be made, and was useful for detecting potential 
sources of bias in the available evidence.
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Background
Systematic reviews are used to synthesize research evi-
dence relating to the effectiveness of an intervention 
[1]. Conclusions of high quality reviews provide a basis 
on which clinicians and researchers can make evidence-
based decisions and recommendations. Accurately 
assessing methodological quality of included studies is 
therefore essential. Quality is a multidimensional concept 
representing the extent to which study design can mini-
mise systematic and non-systematic bias, as well as infer-
ential error [2, 3].
There are numerous instruments available for assessing 
quality of evidence and there remains uncertainty over 
which are the most appropriate to use [4], and how they 
should be used to interpret results [5, 6]. Use of different 
assessment methods can result in significant changes to 
the size and direction of pooled effect sizes [7–9] and it 
is therefore important to consider the properties of the 
assessment methods used.
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Numerical summary scores may be of limited value in 
interpreting the results of meta-analyses [10]. However, 
these scales are widely used in the literature, possibly due 
to their ease of use. Quality assessment based on non-
numerical or domain-based rating systems [11–14] are 
increasingly used, particularly when also seeking to make 
treatment recommendations.
The primary aim of this study was to compare these 
two contrasting methods for assessing methodologi-
cal quality of randomized and non-randomized studies 
included within a systematic review [15]. As part of the 
review the rating system proposed by the United States 
Preventative Services Task Force (USPSTF) [12, 13] was 
used to assess methodological quality and to allow for 
treatment recommendations to be made. We wished to 
compare this domain based rating system to a numeri-
cal scale to determine the potential influence of different 
approaches on treatment effect size within a review. We 
selected the rating scale proposed by Downs and Black 
[16] for comparison as it is one of the most commonly 
used and well validated numerical rating scales [17].
The study objectives were:
1. To determine the effect of quality ratings on pooled 
effect size for primary outcome data from the 
included studies.
2. To determine inter-rater reliability and level of agree-
ment between tools when examining separate com-
ponents of internal and external validity, as well as 
overall ratings assigned to each paper.
Methods
Details of each quality assessment tool
Downs and Black Scale
The Downs and Black Scale consists of 27 questions relat-
ing to quality of reporting (ten questions), external validity 
(three questions), internal validity (bias and confounding) 
(13 questions), and statistical power (one question) (Addi-
tional file 1: Table S1). It has been shown to have high 
internal consistency for the total score assigned (Kuder–
Richardson 20 test: 0.89) as well as all subscales, except 
external validity (0.54); with reliability of the subscales 
varying from “good” (bias) to “poor” (external validity) [16]. 
The original scale provides a total score out of 32 points, 
with one question in the reporting section carrying a pos-
sible two points, and the statistical power question carry-
ing a possible five points. Previous studies have frequently 
employed a modified version by simplifying the power 
question and awarding a single point if a study had suffi-
cient power to detect a clinically important effect, where 
the probability value for a difference being due to chance is 
<5% [18–20]. The modified version which we employed in 
this study therefore has a maximum score of 28. Each paper 
was assigned a grade of “excellent” (24–28 points), “good” 
(19–23 points), “fair” (14–18 points) or “poor” (<14 points).
United States Preventative Services Task Force
In rating quality, the USPSTF system assigns individual 
studies a grade of “good”, “fair”, or “poor” for both inter-
nal and external validity. Assessment criteria are not used 
as rigid rules, but as guidelines with exceptions made if 
there is adequate justification. In general, a “good” study 
meets all criteria for that study design; a “fair” study does 
not meet all criteria but is judged to have no serious flaw 
that may compromise results; and a “poor” study con-
tains a potentially serious methodological flaw. Criteria 
for determining a serious flaw are dependent on study 
design but include lack of adequate randomization or 
allocation concealment in randomized controlled trials; 
failure to maintain comparable groups or account for loss 
to follow-up or lack of similarity between the study pop-
ulation and patients seen in clinical practice [12].
Quality assessment conducted using both tools
Twenty studies were included as part of an updated sys-
tematic review conducted following the “preferred report-
ing items for systematic reviews and meta-analyses” 
(PRISMA) [21] guidelines which examined the effects of an 
exercise intervention for chronic musculoskeletal pain [15] 
(References for included studies are shown in Additional 
file 2: Table S2). Each study was assessed independently 
by two reviewers [GDB, BR] using the Downs and Black 
scale. Discrepancies were resolved via discussion with 
a third reviewer [SOC]. The USPSTF was initially used 
to rate each study by a single reviewer [SOC] and then, 
as recommended by the USPSTF [12, 13], via consensus 
decisions made at meetings between review authors [MT, 
GDB, JB, SM, SOC]. All reviewers had experience of con-
ducting systematic reviews in the area and specific experi-
ence of using both measures. Reviewers were not blinded 
with regards to study authorship, institution, or journal of 
publication. Prior to assessment reviewers met to estab-
lish standardized methods of scoring. Both methods were 
piloted on a sample of papers examining exercise interven-
tions for an unrelated musculoskeletal condition.
Analysis
Inter-rater reliability was examined for the separate 
domains of internal and external validity, as well as for 
overall quality ratings. Agreement between reviewers 
before consensus and agreement between tools were 
determined using the interclass correlation coefficient 
(ICC) based on a mixed-model, two way analysis of vari-
ance (2, k) for absolute agreement and 95% confidence 
intervals (95% CI). For the purposes of the analysis, when 
rating quality using the USPSTF system, the number of 
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relevant criteria which were met according to the design 
of the individual study was used to assign a score out 
of 11. The Downs and Black scale was scored out of 28. 
Scores were converted to a percentage (score for paper/
total possible score × 100) in order to allow for statistical 
comparisons to be made between tools.
Criteria used to determine levels of agreement for ICCs 
were: <0.00 for poor; 0.00–0.20 for fair; 0.21–0.45 for mod-
erate; 0.46–0.75 for substantial and 0.76–1.0 for almost 
perfect agreement [22]. All analyses were performed using 
SPSS version 20.0 (SPSS Inc., Chicago, IL, USA). The grad-
ing system for the Downs and Black scale was modified to 
allow comparisons to be made with the USPSTF system by 
collapsing the “excellent” and “good” ratings together. This 
meant both tools were used to assign a grade of “good”, 
“fair” or “poor” to each study. The influence of methodo-
logical quality (“poor”, “fair”, or “good”) on pooled effect size 
for pain data was determined using a random effects model 
for inverse variance which was used to calculate the stand-
ardized mean difference (SMD) and 95% CI [Review Man-
ager (RevMan) (Computer program); Version 5.0] [23].
Results
Inter-rater reliability for the Downs and Black scale 
across the separate domains of internal and external 
validity indicated substantial to almost perfect agree-
ment (ICC = 0.61; 95% CI 0.26, 0.83 and ICC = 0.76; 95% 
CI = 0.51, 0.90). High levels of agreement were also found 
for total scores (ICC  =  0.94; 95% CI 0.84, 0.97). Scores 
ranged from 15 to 24/28, with a mean of 18.7 (SD: 2.9).
For the USPSTF system, inter-rater reliability for inter-
nal and external validity was also good (ICC  =  0.67; 
95% CI  =  0.33, 0.85 and ICC  =  0.84; 95% CI  =  0.63, 
0.93 respectively). High levels of agreement were also 
observed for total scores assigned (ICC  =  0.85; 95% 
CI = 0.66, 0.94).
There was at least a substantial level of agreement 
between the total scores assigned to each paper using 
both tools (ICC = 0.80; 95% CI = 0.57, 0.92) and overall 
quality ratings were the same for 14/20 studies (Table 1). 
However, the USPSTF system identified a small number 
of studies (n  =  3/20) as “poor” which the Downs and 
Black scale did not. Analysis of pooled effect sizes for 
Table 1 Comparison of quality ratingsassigned to each paper using the Downs and Black (DB) scale and United States 
Preventative Services Task Force (USPSTF) system
Separate scores are given for each section (reporting, internal validity, external validity) and the overall total score. Papers were rated as “Excellent/good”, “fair” or 
“poor” depending on the numerical score assigned to the paper (Excellent/Good = 20–28; Fair = 15–19; Poor = <14).
a Italicized studies indicate where the final grade assigned to the paper differed depending on the quality assessment tool used.
b Total possible score for the modified D&B scale = 28; reporting) = 11; internal validity = 13; external validity = 3; power = 1.
References DB (internal  
validity 
score/13)
USPSTF  
(internal validity 
rating)
DB (external 
validity score/3)
USPSTF  
(external validity 
rating)
DB (total numerical 
scoreb/28 and rating)
USPSTF  
(overall rating)
Bautch et al (1997 ) 8 Poor 1 Fair 18; fair Poora
Bautch et al. (2000) 6 Fair 1 Fair 17; fair Fair
Bircan et al. (2008) 7 Fair 1 Fair 18; fair Fair
Dias et al. (2003) 8 Poor 1 Fair 18; fair Poora
Ettinger et al. (1997) 11 Good 3 Fair 25; good Faira
Evcik et al. (2002) 5 Fair 1 Good 15; fair Fair
Ferrell et al. (1997) 8 Fair 1 Fair 19; fair Fair
Holtgrefe et al. (2007) 7 Fair 3 Fair 18; fair Fair
Koldas Doğan et al. 
(2008)
7 Fair 0 Fair 17; fair Fair
Kovar et al. (1992) 9 Fair 3 Fair 21; good Faira
Lemstra et al. (2005) 11 Good 3 Good 24; good Good
Martin et al. (1996) 7 Fair 1 Fair 16; fair Fair
Messier et al. (2004) 11 Fair 3 Fair 23; good Faira
Meyer et al. (2000) 8 Poor 0 Poor 19; fair Poora
Miller et al. (2006) 8 Fair 1 Fair 17; fair Fair
Nichols et al. (1994) 8 Fair 1 Fair 15; fair Fair
Rasmussen-Barr et al. 
(2009)
9 Good 2 Good 21; good Good
Rooks et al. (2007) 10 Good 3 Good 24; good Good
Talbot et al. (2003) 7 Fair 2 Good 18; fair Fair
Valim et al. (2003) 7 Fair 1 Poor 19; fair Fair
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pain data revealed substantial differences between these 
studies compared to those rated as “fair” or “good”, with 
a SMD (95% CI) of −2.51 (−4.21, −0.82); −0.45 (−0.65, 
−0.25); and −0.38 (−0.69, −0.08) respectively (Figure 1).
Discussion
Comparison between tools
This study examined the inter-rater reliability and level 
of agreement between two different approaches used 
to assess the methodological quality of randomized 
and non-randomized studies within a systematic 
review [15]. Both tools demonstrated good inter-rater 
reliability across the separate domains of internal and 
external validity, as well as for the final grade assigned 
to each paper. Although both tools assigned markedly 
different weighting to the internal and external validity 
sections, agreement was also good for the final grades 
assigned.
Study or Subgroup
11.2.1 good
Lemstra 2005
Rasmussen-Barr 2009
Rooks 2007
Subtotal (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 0.38, df = 1 (P = 0.54); I² = 0%
Test for overall effect: Z = 2.50 (P = 0.01)
11.2.2 fair
Bautch 2000
Bircan 2008
Ettinger 1997
Evcik 2002
Ferrell 1997
Holtgrefe 2007
Koldos Dogan 2008
Kovar 1992
Martin 1996
Messier 2004
Miller 2006
Nichols 1994
Talbot 2003
Valim 2003
Subtotal (95% CI)
Heterogeneity: Tau² = 0.04; Chi² = 17.70, df = 10 (P = 0.06); I² = 44%
Test for overall effect: Z = 4.37 (P < 0.0001)
11.2.3 poor
Bautch 1997
Dias 2003
Meyer 2000
Subtotal (95% CI)
Heterogeneity: Tau² = 1.93; Chi² = 16.42, df = 2 (P = 0.0003); I² = 88%
Test for overall effect: Z = 2.91 (P = 0.004)
Total (95% CI)
Heterogeneity: Tau² = 0.26; Chi² = 75.23, df = 15 (P < 0.00001); I² = 80%
Test for overall effect: Z = 4.63 (P < 0.00001)
Mean
0
18
51.3
0
2.199
2.14
3.4
36.4
0
34.9
3.77
0
6.24
4.1
78.1
1.07
3.42
2.71
-100
0.45
SD
0
21
21.4
0
1.88
0.6
1.3
25.6
0
30.8
1.73
0
4.2
2.65
15.1
0.8
2.5
0.65
28
0.1
Total
0
36
51
87
0
13
144
28
9
0
19
47
0
80
44
10
17
32
443
15
25
8
48
578
Mean
0
26
61.1
0
2.65
2.4
6
55.9
0
40
4.77
0
6.02
6.1
80.2
1.57
4.6
3.51
0
1.6
SD
0
35.5
20.4
0
1.41
0.6
3.3
21
0
21.8
1.22
0
3.9
3.2
10.8
1.12
2.18
0.73
28
0.5
Total
0
35
50
85
0
13
149
26
10
0
18
45
0
78
43
9
17
28
436
15
25
8
48
569
Weight
7.2%
7.6%
14.9%
5.5%
8.4%
6.7%
4.7%
6.2%
7.5%
8.0%
7.4%
4.9%
6.0%
7.0%
72.2%
5.5%
4.8%
2.6%
12.9%
100.0%
IV, Random, 95% CI
Not estimable
-0.27 [-0.74, 0.20]
-0.47 [-0.86, -0.07]
-0.38 [-0.69, -0.08]
Not estimable
-0.26 [-1.04, 0.51]
-0.43 [-0.66, -0.20]
-1.04 [-1.61, -0.47]
-0.80 [-1.74, 0.14]
Not estimable
-0.19 [-0.83, 0.46]
-0.66 [-1.08, -0.24]
Not estimable
0.05 [-0.26, 0.37]
-0.68 [-1.11, -0.24]
-0.15 [-1.05, 0.75]
-0.50 [-1.19, 0.18]
-0.49 [-1.01, 0.02]
-0.45 [-0.65, -0.25]
-1.13 [-1.90, -0.35]
-3.52 [-4.42, -2.61]
-3.02 [-4.57, -1.46]
-2.51 [-4.21, -0.82]
-0.70 [-1.00, -0.40]
Experimental Control Std. Mean Difference Std. Mean Difference
IV, Random, 95% CI
-4 -2 0 2 4
Favours experimental Favours control
Figure 1 Estimates of treatment effect size for pain data according to quality rating using the United States Preventative Services Task Force (USP-
STF) system.
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While overall analysis indicated a high level of agree-
ment; the domain-based USPSTF system identified a 
number of the studies (3/20) as “poor” due to potential 
sources of bias. These studies were found to have sub-
stantially greater and less precise pooled effect sizes com-
pared to those rated as “fair” or “good” using the USPSTF 
system (Figure 1).
In general, the USPSTF system was also found to be 
more conservative, with six of the 20 studies assigned a 
lower overall quality rating (Table 1). One possible reason 
accounting for this finding is that the USPSTF system con-
siders a number of potentially invalidating methodologi-
cal flaws in its assessment. The Downs and Black scale on 
the other hand assigns each question a single point (except 
in one case where a single question may be awarded two 
points). As a result, a study can contain a potentially seri-
ous flaw, and still be rated as “fair” or “good” quality.
Since the USPSTF system gives equal weighting to 
external validity, this might have accounted for the dif-
ferences. However, the reasons for studies being rated as 
“poor” generally related to issues of internal validity, such 
as inadequate allocation concealment in randomized 
controlled trials, or possible selection bias occurring due 
to unequal distribution of primary outcomes at baseline. 
Schulz and co-authors [24] suggest that allocation con-
cealment is the element of quality that is associated with 
the greatest risk of bias. While the greater effect sizes 
compared to those rated as “fair” or “good” was based on 
only three “poor” quality studies, others have reported 
similar findings using larger numbers of included studies 
[24–27].
The influence of other quality factors on effect size are 
less certain [5]; and various issues apart from methodo-
logical quality may contribute to inexact treatment effect 
sizes, including heterogeneity of study interventions 
or sample populations [28, 29]. Although we included 
studies which were generally homogenous in terms of 
intervention type and sample population, it is uncer-
tain whether differences in methodological quality alone 
would account for the variations in treatment effect 
observed in those studies rated as “poor”.
Strengths and limitations
These results should be considered with a degree of 
caution given the relatively small number of included 
studies, and assessing a larger number of heterogene-
ous studies would be required to provide more certain 
evidence in support of these findings. Despite this, the 
study provides further support for the contention that 
numerical summary scores should not be used for the 
assessment of methodological quality, or for determin-
ing cut-off criteria for study inclusion. In practical terms, 
within the specific example of a single systematic review 
[15], a commonly used numerical summary scale failed to 
identify the small number of included studies which con-
tained important sources of potential bias according to 
the domain based system.
While we found a good level of reliability between inde-
pendent assessments for both tools it is acknowledged 
that this could be due to the pilot phase used to stand-
ardize scoring methods, and the relatively small number 
of studies [30, 31]. The conversion of domain based USP-
STF ratings to a numerical value for reliability assessment 
is also a limitation; however this was to allow for com-
parison to be made with the Downs and Black scale and 
since it would provide a more robust and sensitive meas-
ure than comparing ratings of “poor” “fair” or “good”. A 
further limitation is that there is no gold standard with 
which quality assessment tools can be compared. The 
study also did include a qualitative assessment of utility.
We selected the Downs and Black scale as it is one of 
the most widely used and well validated tools for assess-
ment of both randomized and non-randomized studies 
[18]. However, in comparison to the USPSTF system, a 
number of limitations associated with its use were iden-
tified. In particular, the ability of the Downs and Black 
scale to differentiate studies containing potential sources 
of bias was limited in comparison to the USPSTF system.
Recommendations
Summary quality scales combine information on sev-
eral methodological features in a single numerical value, 
whereas component or domain-based approaches exam-
ine key dimensions or outcomes individually [6, 12–14]. 
The use of summary scores from numerical rating scales 
for assessment of methodological quality has been called 
into question [4, 8, 32]. One issue is that they frequently 
incorporate items such as quality of reporting, ethical 
issues or statistical analysis techniques which are not 
directly related to quality or to potential bias [4]. This 
is an important distinction, since the inclusion of such 
items may be misleading and a study containing method-
ological bias, but which is well reported, can potentially 
still be rated as high quality. In particular, the practice 
of using numerical scores to identify trials of apparent 
low or high quality in a systematic review is not recom-
mended [32].
Analysis of individual components of quality may over-
come many of the shortcomings of composite scores. The 
component approach takes into account the importance 
of individual quality domains, and that the direction of 
potential bias varies between the contexts in which stud-
ies are performed [33]. Decisions relating to assessment 
of methodological quality when using domain-based rat-
ing systems are therefore dependent upon the particu-
lar research area under consideration, since important 
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components relating to bias are not universal. The use 
of a standard set of quality components across all clini-
cal areas is not recommended [5] and more specific 
guidance may be required when using these types of 
assessment tool [33, 34]. Review authors should there-
fore remain cautious when using a domain based system 
to assess methodological quality and formulate guideline 
recommendations.
Conclusions
Here we evaluated a domain-based rating system and 
demonstrated its ability to successfully differentiate 
studies associated with potentially exaggerated treat-
ment effects. Domain-based rating systems provide a 
structured framework by which studies can be assessed 
in a qualitative manner, allowing for the identification 
of potential sources of bias, firstly within the individual 
studies, but also in the context of the available body of 
evidence under review. This is important as quality of 
evidence can vary across outcomes reported in the same 
study, and some outcomes may be more prone to bias 
than others. For example, bias due to lack of allocation 
concealment may be more likely for subjective outcomes, 
such as quality of life [29]. How to account for any poten-
tial bias in the analysis remains in question, but the cur-
rent Cochrane guidelines [11] recommend examining 
studies containing potential methodological bias as a 
separate sub-category in a sensitivity analysis.
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